Pricer AB (publ) (STO:PRIC.B)

Sage Therapeutics Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	240.7	489.2	255.6	217.48	16.55	262.41
Cash & Short-Term Investments	240.7	489.2	255.6	217.48	16.55	262.41
Cash Growth	-5.57%	91.39%	17.53%	1214.29%	-93.69%	35.10%
Accounts Receivable	338.2	409.6	294.8	305.7	367.78	236.33
Other Receivables	192.1	155.7	210.9	278.35	205.29	98.45
Receivables	530.3	565.3	505.7	584.05	573.07	334.78
Inventory	610.4	667.1	653.6	670.26	633.05	301.53
Prepaid Expenses	35.6	12.4	10	7.24	8.56	4.27
Other Current Assets	-	6.7	9.2	5.16	4.64	4.49
Total Current Assets	1,417	1,741	1,434	1,484	1,236	907.48
Property, Plant & Equipment	149.7	163.7	108.7	88.99	77.55	73.95
Goodwill	-	289.9	280	280.83	258.09	253.31
Other Intangible Assets	407.3	-	0.1	0.05	0.07	0.5
Long-Term Deferred Tax Assets	53.4	55.3	67	67.46	61.51	75.01
Long-Term Deferred Charges	-	127.1	118.2	115.73	97.6	84.25
Other Long-Term Assets	4.7	4.7	-	-	-	-
Total Assets	2,032	2,381	2,008	2,037	1,731	1,394
Accounts Payable	398.1	439.5	588.2	842.1	650.92	384.37
Accrued Expenses	165.2	136.9	106.6	111.87	61.61	64.32
Short-Term Debt	-	-	-	-	111.54	-
Current Portion of Long-Term Debt	-	250	-	-	-	-
Current Portion of Leases	11.5	11.8	9.3	13.85	12.76	11.77
Current Unearned Revenue	11.9	26.6	18.8	30.56	22.22	31.73
Other Current Liabilities	43	33.8	30	29.98	28.61	25.69
Total Current Liabilities	629.7	898.6	752.9	1,028	887.66	517.88
Long-Term Debt	293.2	292.1	240.1	239.96	-	-
Long-Term Leases	39.5	43.7	9.9	14.25	24.03	33.53
Other Long-Term Liabilities	26.7	31.3	48	22.47	22.13	24.04
Total Liabilities	989.1	1,266	1,051	1,305	933.81	575.45
Common Stock	164	164	164	110.97	110.97	110.97
Additional Paid-In Capital	617.4	617.4	617.4	389.81	390.38	393.16
Retained Earnings	206.3	247.2	114.7	162.51	268.04	299.11
Comprehensive Income & Other	55.3	87.1	61.1	68.91	27.48	15.8
Shareholders' Equity	1,043	1,116	957.2	732.2	796.87	819.05
Total Liabilities & Equity	2,032	2,381	2,008	2,037	1,731	1,394
Total Debt	344.2	597.6	259.3	268.06	148.33	45.3
Net Cash (Debt)	-103.5	-108.4	-3.7	-50.58	-131.78	217.11
Net Cash Growth	-	-	-	-	-	55.55%
Net Cash Per Share	-0.63	-0.66	-0.03	-0.45	-1.19	1.95
Filing Date Shares Outstanding	163.4	163.38	163.37	110.35	110.32	110.09
Total Common Shares Outstanding	163.4	163.38	163.37	110.35	110.32	110.09
Working Capital	787.3	842.1	681.2	455.82	348.2	389.6
Book Value Per Share	6.38	6.83	5.86	6.64	7.22	7.44
Tangible Book Value	635.7	825.8	677.1	451.33	538.71	565.24
Tangible Book Value Per Share	3.89	5.05	4.14	4.09	4.88	5.13
Machinery	-	203.2	162.4	118.53	86.49	65.06
Leasehold Improvements	-	5.6	5.2	5.18	4.65	3.11
Order Backlog	-	725.6	394.2	493	383	495

Source: S&P Global Market Intelligence. Standard template. Financial Sources.